American Well Co. (NYSE:AMWL) Receives $33.25 Average PT from Analysts

Shares of American Well Co. (NYSE:AMWL) have earned a consensus rating of “Hold” from the eleven ratings firms that are covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $33.25.

A number of equities research analysts recently commented on the company. Zacks Investment Research raised American Well from a “sell” rating to a “hold” rating in a report on Monday, March 29th. Cowen decreased their price target on American Well from $41.00 to $35.00 and set an “outperform” rating for the company in a report on Thursday, March 25th. Credit Suisse Group downgraded American Well from an “outperform” rating to a “neutral” rating and set a $41.00 price target for the company. in a report on Wednesday, January 27th. Stifel Nicolaus assumed coverage on American Well in a report on Friday, December 18th. They issued a “hold” rating and a $29.00 price target for the company. Finally, Morgan Stanley decreased their price target on American Well from $33.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, April 1st.

Shares of AMWL stock opened at $16.89 on Monday. American Well has a fifty-two week low of $15.53 and a fifty-two week high of $43.75. The stock’s 50-day simple moving average is $22.35 and its 200-day simple moving average is $26.76.

American Well (NYSE:AMWL) last released its earnings results on Tuesday, March 23rd. The company reported ($0.51) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.25). The company had revenue of $60.40 million during the quarter, compared to analysts’ expectations of $54.60 million. American Well’s quarterly revenue was up 34.2% on a year-over-year basis. Sell-side analysts predict that American Well will post -3.38 EPS for the current year.

In related news, CEO Roy Schoenberg sold 1,489,137 shares of the business’s stock in a transaction that occurred on Wednesday, January 20th. The stock was sold at an average price of $26.43, for a total transaction of $39,357,890.91. Following the completion of the sale, the chief executive officer now directly owns 3,104,512 shares in the company, valued at $82,052,252.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Kurt Knight sold 16,233 shares of the business’s stock in a transaction that occurred on Monday, April 5th. The stock was sold at an average price of $18.02, for a total value of $292,518.66. Following the sale, the chief operating officer now owns 1,185,093 shares of the company’s stock, valued at $21,355,375.86. The disclosure for this sale can be found here. Insiders sold 2,292,579 shares of company stock valued at $59,291,818 over the last 90 days.

Institutional investors and hedge funds have recently modified their holdings of the stock. Caledonia Private Investments Pty Ltd purchased a new stake in shares of American Well during the third quarter worth approximately $190,772,000. Emerald Advisers LLC grew its holdings in American Well by 94.3% in the 4th quarter. Emerald Advisers LLC now owns 401,614 shares of the company’s stock valued at $10,173,000 after buying an additional 194,964 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in American Well in the 3rd quarter valued at $1,186,000. State of Wisconsin Investment Board purchased a new stake in American Well in the 4th quarter valued at $216,000. Finally, Clearbridge Investments LLC grew its holdings in American Well by 2.2% in the 4th quarter. Clearbridge Investments LLC now owns 102,160 shares of the company’s stock valued at $2,588,000 after buying an additional 2,160 shares in the last quarter. Hedge funds and other institutional investors own 18.97% of the company’s stock.

American Well Company Profile

American Well Corporation provides a telehealth application that connects and enables providers, insurers, patients, and innovators to deliver access to healthcare. Its application offers urgent care; pediatrics; therapy; menopause nutrition; menopause counseling; telestroke; population health management; telepsychiatry; pregnancy and postpartum nutrition; pregnancy and postpartum therapy; breastfeed support; menopause care; pregnancy and postpartum care; and chromic disease management services.

Read More: What are high-yield dividend stocks?

Analyst Recommendations for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.